Brigitte Mohr

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

Christian Thiede, Christine Steudel, Brigitte Mohr et al. · Blood · 2002 · 1.7K citations · Full text

Medicine, Genetics, Hematology +14

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

Uwe Platzbecker, Martin Wermke, J. Radke et al. · Leukemia · 2011 · 395 citations · Full text

Medicine, Hematology, Pharmacology +17

Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System

Christoph Röllig, Martin Bornhäuser, Christian Thiede et al. · Journal of Clinical Oncology · 2011 · 266 citations · Full text

Public Health, Hematology, Oncology +16

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

Christian Thiede, Mareike Florek, Martin Bornhäuser et al. · Bone Marrow Transplantation · 1999 · 259 citations

Life Sciences, Genetics, Molecular Biology +11

Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

Christian Thiede, Martin Bornhäuser, Uta Oelschlägel et al. · Leukemia · 2001 · 220 citations

Medicine, Hematology, Immunology +17